Your browser doesn't support javascript.
loading
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu, Xu-Sheng; Zhou, Lu-Meng; Yuan, Ling-Ling; Gao, Yan; Kui, Xue-Yan; Liu, Xiao-Yu; Pei, Zhi-Jun.
Afiliación
  • Liu XS; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Zhou LM; Hubei Key Laboratory of Embryonic Stem Cell Research, Shiyan, China.
  • Yuan LL; Department of Nuclear Medicine, Huanggang Central Hospital, Huanggang, China.
  • Gao Y; Department of Pathology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Kui XY; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Liu XY; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Pei ZJ; Department of Nuclear Medicine and Institute of Anesthesiology and Pain, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
Front Immunol ; 12: 724741, 2021.
Article en En | MEDLINE | ID: mdl-34335635

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Adenocarcinoma del Pulmón / Nucleofosmina / Neoplasias Pulmonares / Metiltransferasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Adenocarcinoma del Pulmón / Nucleofosmina / Neoplasias Pulmonares / Metiltransferasas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: China